ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 220 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,278,266 | -8.2% | 35,856 | +18.8% | 0.00% | 0.0% |
Q2 2023 | $1,392,250 | +37.2% | 30,181 | +19.2% | 0.00% | – |
Q1 2023 | $1,015,051 | -9.3% | 25,313 | +4.8% | 0.00% | -100.0% |
Q4 2022 | $1,119,379 | +20.5% | 24,161 | +7.7% | 0.00% | 0.0% |
Q3 2022 | $929,000 | -35.8% | 22,428 | -7.5% | 0.00% | 0.0% |
Q2 2022 | $1,446,000 | -16.4% | 24,237 | +1.8% | 0.00% | 0.0% |
Q1 2022 | $1,730,000 | +3.5% | 23,817 | +19.8% | 0.00% | 0.0% |
Q4 2021 | $1,672,000 | +8.0% | 19,878 | +15.8% | 0.00% | 0.0% |
Q3 2021 | $1,548,000 | +9.9% | 17,169 | +16.3% | 0.00% | 0.0% |
Q2 2021 | $1,408,000 | -25.9% | 14,765 | -11.5% | 0.00% | 0.0% |
Q1 2021 | $1,901,000 | +44.6% | 16,692 | +75.7% | 0.00% | 0.0% |
Q4 2020 | $1,315,000 | +108.7% | 9,499 | +23.8% | 0.00% | 0.0% |
Q3 2020 | $630,000 | +44.2% | 7,670 | +37.2% | 0.00% | – |
Q2 2020 | $437,000 | +99.5% | 5,590 | +13.5% | 0.00% | – |
Q1 2020 | $219,000 | +1360.0% | 4,926 | +1616.4% | 0.00% | – |
Q3 2017 | $15,000 | -62.5% | 287 | -56.2% | 0.00% | – |
Q2 2017 | $40,000 | -13.0% | 656 | -2.5% | 0.00% | – |
Q1 2017 | $46,000 | +4.5% | 673 | +6.8% | 0.00% | – |
Q4 2016 | $44,000 | – | 630 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |